Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Revatio (sildenafil citrate) - Important Safety Information from Pfizer Healthcare Ireland as approved by the Irish Medicines Board

04 October 2011

Important Safety Information relating to increased risk of mortality in paediatric patients with pulmonary arterial hypertension with the use of higher than recommended doses of Revatio (sildenafil citrate).

Pfizer Revatio DHPC 04.09.11.pdf





Date Printed: 25 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971